The Man Who Wrote the DSM Warned Us About Overdiagnosis — So Why Not Gender? - Allen Frances (#8)
10 April 2025
With Allen Frances
Global
Dr Allen Frances chaired the DSM-IV Task Force and spent decades warning that psychiatric diagnosis had expanded too far. His conversation with the Beyond Gender hosts is revealing precisely where it breaks down: he applies diagnostic scepticism broadly but hedges on gender dysphoria. That tension — in the man who helped shape modern diagnostic criteria — throws fresh light on the Cass Review's call for caution and NHS England's evidence-led reversal on puberty blockers for young people.
Dr Allen Frances chaired the DSM-IV Task Force and spent the years following its publication warning that psychiatry had overreached. His consistent argument — that diagnostic categories had been drawn too broadly, capturing ordinary distress and mild variation alongside genuine disorder — made him one of the field's most prominent internal critics. It is that reputation that makes his appearance on Beyond Gender both illuminating and, at moments, unexpectedly revealing. The early part of the conversation covers ground Frances has mapped before. He describes how diagnoses, once attached, calcify into identity, how pharmaceutical incentives pull clinicians towards labelling the mild, and how the resolution of a problem does not automatically dissolve the category used to frame it. His account of the rapid expansion of autism diagnoses resonates with a finding the Cass Review flagged in England: that a significant number of young people referred to gender services also carried autism diagnoses, raising questions about whether complex neurodevelopmental profiles were being redirected too readily into a single clinical pathway. The episode's most striking passage arrives when the conversation turns to gender dysphoria. Frances does not apply the sceptical lens he has spent decades refining. He expresses confusion, qualifies his answers, and declines to draw the conclusions that his own framework might seem to require. He reveals that he had wanted gender identity disorder removed from the DSM entirely, but his reasoning sits uneasily with the hosts' reading of the accumulated evidence. The disagreement is genuine and conducted in good faith, which makes the exchange more valuable than most. From a UK standpoint, what Frances leaves implicit is worth making explicit. The Cass Review concluded that the evidence base for medicalising gender distress in young people was exceptionally thin. NHS England responded in 2024 by suspending puberty blocker prescriptions outside clinical research settings, and by commissioning a new care model that places thorough psychosocial assessment before any medical pathway. These are precisely the kinds of corrective that Frances' general principles about diagnostic caution would appear to demand — applied, in this case, to the specific field where he withholds them. The legal dimension surfaces in the episode too. The Bell v Tavistock case established in the High Court that children were unlikely to be able to give informed consent to puberty blockers given the deep uncertainty about their long-term effects, a ruling later complicated by the Court of Appeal before being effectively resolved by NHS England's own clinical policy change. Frances' admission that he finds the territory confusing because it is confusing does not resolve those questions, but it registers them honestly. A man who built a career on opposing diagnostic overconfidence acknowledging that he cannot apply his own framework cleanly to gender is itself a significant data point. What the episode offers is not resolution but a different kind of rigour — a sustained, respectful collision between positions that do not wholly yield to each other. Frances' willingness to say he does not know, in a debate where certainty is routinely performed, is the conversation's most durable contribution.
